Harel Insurance Investments & Financial Services Ltd. Clene Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

  • $5.8 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 26, 2021
SELL
$6.98 - $13.33 $243,678 - $465,363
-34,911 Closed
0 $0
Q1 2021

Apr 27, 2021
BUY
$6.39 - $16.3 $223,081 - $569,049
34,911 New
34,911 $1.49 Million

Others Institutions Holding CLNN

# of Institutions
6
Shares Held
230K
Call Options Held
0
Put Options Held
25K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $273M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email